112032 ⎘
Bacteriophages; Details dsDNA Bacteriophages; Siphoviridae New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
BACTERIOPHAGE LAMBDA-VACCINE SYSTEM
#2METHOD FOR SCREENING FOR MODIFICATIONS IN THE INFECTIVITY RANGE OF BACTERIOPHAGES DUE TO EPIGENETIC IMPRINTING
#3PRODUCTION OF LYTIC PHAGES
#4PRODUCTION BACTERIAL CELLS AND USE THEREOF IN PRODUCTION METHODS
#5DELIVERY OF THERAPEUTIC RNAS VIA ARRDC1-MEDIATED MICROVESICLES
#6Production of lytic phages
#7Production bacterial cells and use thereof in production methods
#8Production of lytic phages
#9Production bacterial cells and use thereof in production methods
#10Method of treating pathogenic bacterial infectious diseases
#11ARTIFICIAL RIBOSOMES FOR FULLY PROGRAMMABLE SYNTHESIS OF NONRIBOSOMAL PEPTIDES
#12Chimeric bacteriophage lysin with activity against bacteria
#13Delivery of therapeutic RNAs via ARRDC1-mediated microvesicles
#14Compositions of and methods for in vitro viral genome engineering
#15Anti-CRISPR polynucleotides and polypeptides and methods of use
#16Mutants of the bacteriophage lambda integrase
#17Anti-CRISPR genes and proteins and methods of use
#18Fusion protein comprising bacteriophage λ GpD fused to a GP2 antigen derived from HER-2/neu
#19Artificial ribosomes for fully programmable synthesis of nonribosomal peptides
#20Compositions of and methods for in vitro viral genome engineering
#21Compositions of and methods for in vitro viral genome engineering
#22Chimeric bacteriophage lysin with activity against staphylococci bacteria
#23Methods and compositions for delivery of CRISPR based antimicrobials
#24Lipid bilayer-integrated SPP1 connector protein nanopore and SPP1 connector protein variants for use as lipid bilayer-integrated nanopore
#25Mutants of the bacteriophage lambda integrase
#26Chimeric antibacterial polypeptides
#27Polypeptides specific to capsular type strains
#28DNA vector production system
#29Diagnosis and treatment of mycobacteria infections
#30Compositions of and methods for in vitro viral genome engineering
#31bacteriophage and uses thereof
#32Chimeric bacteriophage lysin with activity against staphylococci bacteria
#33Chimeric antibacterial polypeptides
#34Staphylococcal Phage2638A endolysin amidase domain is lytic for
#35MUTEINS OF THE BACTERIOPHAGE LAMBDA INTEGRASES
#36Chimeric bacteriophage lysin with activity against bacteria
#37Bacteriophage adhesion proteins
#38CHROMOSOME-BASED PLATFORMS
#39Bacteriophage lytic enzymes as alternative antimicrobials
#40Antibacterial phage peptides and methods of use thereof
#41Phage lambda display constructs
#42Bacteriophage and antibacterial composition comprising the same
#43Modified vectors for organelle transfection
#44Sensing phage-triggered ion cascade (SEPTIC)
#45Chromosome-based platforms
#46Lambdoid bacteriophage vectors for expression of foreign proteins
#47Chromosome-based platforms
#48Chromosome-based platforms
#49Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system